Controlled Substances, Drug Schedules, and FDA Boxed Warnings

Key Points

• Boxed Warnings (formerly Black Box Warnings) are the highest FDA safety warning, appearing on drug labels when post-market evidence identifies serious risks; nurses must verify current drug references for boxed warning status.
• The DEA Controlled Substances Act (CSA) classifies regulated drugs into Schedules I–V based on medical use, abuse potential, and dependence liability; Schedule II (opioids, stimulants) carries the strictest controls.
• Schedule II prescriptions must be written or electronically transmitted — phone/fax orders are not accepted; refills are not allowed.
• Controlled substance waste occurs when a full dose is not administered; waste must be disposed of using a specific process and requires a co-signature by a second licensed staff member.
• Substance use disorder (SUD) in health professionals must be recognized and reported; behavioral and physical signs in a colleague, combined with drug diversion patterns, trigger a mandatory reporting obligation.
• Drug disposal: Nurses teach patients to use authorized collection sites or National Take Back events to safely dispose of unused controlled substances.
• In SBON investigations, drug diversion/substance-abuse allegations are among the most frequent professional-conduct complaint categories.
• Controlled-substance wastage errors (inaccurate counts or poor disposal documentation) are also recurrent board-investigation triggers.

Pathophysiology

Federal law creates layered regulatory controls for drugs with abuse and dependence potential, spanning FDA oversight of drug safety to DEA enforcement of controlled substance handling. Nurses must operate within both systems at every step of medication management.

FDA Boxed Warnings

The U.S. Food and Drug Administration (FDA) approves drugs based on evidence that benefits outweigh risks. However, safety problems can surface after approval when a drug is used in broader populations.

Boxed Warnings (formerly Black Box Warnings) are the highest-level safety warning the FDA can assign:

• They appear directly on the drug’s label and in current evidence-based drug references.
• They highlight the drug’s most serious risks, which may include life-threatening adverse effects.
• A boxed warning can be added, modified, or removed at any time as post-market evidence accumulates.
• Clinical example: Levofloxacin (a fluoroquinolone antibiotic) received a boxed warning after post-market data showed irreversible tendon rupture. The FDA now recommends reserving levofloxacin for indications with no alternative treatment options.

Nursing implication: Always verify current drug information in a current evidence-based drug reference before administering a medication — boxed warning status can change after a drug has been on the market.

DEA and the Controlled Substances Act (CSA)

The U.S. Drug Enforcement Administration (DEA) enforces federal regulations for controlled substances through the Controlled Substances Act (CSA), which governs the manufacture, distribution, and dispensing of drugs with abuse potential. When state law and federal law conflict, health care professionals must follow the more stringent of the two.

Drug Schedules I–V

The CSA classifies controlled substances into five schedules based on medical use, abuse potential, and dependence liability:

Schedule	Definition	Examples
I	No currently accepted medical use; high abuse potential and severe dependence potential	Heroin, LSD, marijuana
II	High abuse potential; severe psychological or physical dependence; accepted medical use	Oxycodone, fentanyl, hydromorphone (Dilaudid), meperidine (Demerol), methadone, cocaine; stimulants: Adderall, Ritalin
III	Moderate to low dependence potential; less abuse potential than I and II	Tylenol with codeine, ketamine, anabolic steroids, testosterone
IV	Low abuse potential; low dependence risk	Alprazolam (Xanax), diazepam (Valium), lorazepam (Ativan), zolpidem (Ambien), tramadol
V	Lowest abuse potential; limited narcotic quantities; antidiarrheal, antitussive, or analgesic use	Robitussin AC with codeine, Lomotil, pregabalin (Lyrica)

Federal Laws for Controlled Substances

Prescriptions:

• A prescription for a controlled substance may only be written by a provider with a DEA registration number.
• Schedule II prescriptions must be written or electronically transmitted via DEA-approved software — telephone and fax orders are not accepted.
• Schedule II refills are not permitted; a new prescription is required each time.
• Schedule III and IV medications may be refilled up to five times.
• State law determines the validity period for Schedule II prescriptions (e.g., some states allow only 60 days).

Records:

• A closed system of record-keeping tracks controlled substances from pharmacy receipt → patient administration → waste disposal.
• Inventory counts are performed frequently — often requiring a physical count by two licensed staff members at the start of each shift.
• Detailed documentation is required for every administration of a controlled substance.

Waste:

• Waste occurs when a full dose is not administered to the patient (e.g., only 2 mg of a 4 mg morphine dose is given).
• Wasted medication must be disposed of differently from regular medications (e.g., flushed down the sink or via a specific disposal pathway).
• Waste disposal requires a co-signature from a second licensed staff member.
• Deviation from waste documentation procedures is a red flag for drug diversion investigations.

Drug Diversion: Tampering

Tampering is the most dangerous form of drug diversion. It occurs when a health care worker removes medication from a syringe, vial, or other container for personal use and replaces it with saline, sterile water, or another clear liquid. The tampered container is then unknowingly administered to the patient — who receives no therapeutic medication.

Tampering:

• Places patients at direct risk for inadequate treatment (e.g., untreated pain).
• Exposes patients to potential infection if non-sterile fluids are used as replacement.
• Is a criminal offense prosecuted at the federal level.

Substance Use Disorder in Health Professionals

Substance use disorder (SUD) can affect health care professionals regardless of age, occupation, or background. Health professionals with SUD are often unidentified and may continue practicing while placing patients at risk.

Warning signs that a colleague may have SUD include:

Category	Signs
Behavioral	Changes in job performance, extended absences from the unit, frequent bathroom trips, arriving late or leaving early, excessive medication errors
Physical	Subtle changes in appearance over time, increasing isolation from colleagues, inappropriate verbal or emotional responses, confusion, memory lapses
Drug diversion patterns	Incorrect opioid counts, large amounts of documented opioid wastage, patients reporting unrelieved pain when that nurse was assigned, increased administration of opioids when that nurse is on shift

Reporting obligation: Nurses who observe signs of SUD in a colleague must report to their supervisor and, in some states, to the State Board of Nursing (SBON). Early identification and treatment protects patients and gives the affected nurse the best chance for recovery.

Many states offer professional assistance programs — voluntary, non-disciplinary rehabilitation programs that allow nurses with SUD to continue employment under SBON monitoring while in recovery.

Safe Disposal of Controlled Substances

The Secure and Responsible Drug Disposal Act (2010) established mechanisms for patients to safely dispose of unused controlled substances, including:

• National Prescription Drug Take Back Days (authorized by DEA).
• Authorized collection receptacles at pharmacies and health care facilities.

Nursing implication: Teach patients prescribed controlled substances (especially opioids) how to safely dispose of unused medication to prevent diversion, accidental ingestion, or environmental contamination.

Classification

• Boxed Warning: FDA’s highest drug safety warning; appears on drug label and references; can be updated post-market.
• Controlled Substances Act (CSA): Federal law classifying regulated drugs into Schedules I–V.
• Schedule II: Highest-risk controlled substances with accepted medical use; strictest prescription controls.
• Waste: The portion of a controlled substance dose not administered to the patient; requires specific disposal and co-signature.
• Closed system: DEA record-keeping requirement tracking controlled substances from pharmacy to patient to disposal.
• Tampering: Form of drug diversion in which medication is removed and replaced with a clear substitute; directly harms patients.
• Substance use disorder (SUD): Illness from repeated substance misuse; can affect health professionals; requires mandatory reporting when suspected in a colleague.
• Professional-conduct allegation linkage: Diversion, on-duty intoxication, and controlled-substance wastage irregularities are common triggers for board investigation.
• Wastage-falsification consequence domain: Unattended controlled medications plus false “wastage” documentation can trigger board fines, public discipline, and substantial legal-defense expense.
• PDMP: Prescription Drug Monitoring Program; state-level electronic database tracking controlled substance prescriptions to identify diversion and misuse patterns.

Nursing Assessment

NCLEX Focus

Know the five DEA drug schedules and the drugs in each, especially Schedule II (opioids and stimulants). Know Schedule II prescription rules (no phone/fax, no refills). Know that waste requires co-signature of a second licensed staff member. Recognize the behavioral and physical signs of SUD in a colleague as a mandatory reporting situation. Know that boxed warnings must be checked in current drug references.

• Assess medication reference for current boxed warning status before administering a new or unfamiliar drug.
• Assess controlled substance counts at the beginning of each shift; report discrepancies immediately.
• Assess opioid administration records for patterns suggesting diversion: patients reporting inadequate pain relief, high documented wastage, or count discrepancies.
• Assess colleague behavior and appearance for signs of SUD; apply objective observation rather than assumption.
• Assess patients who are prescribed controlled substances at discharge for ability to safely store and dispose of unused medications.

Nursing Interventions

• Verify controlled substance orders include all required elements; confirm that Schedule II prescriptions are not telephone or fax orders.
• Always obtain a second licensed staff member co-signature when wasting a controlled substance; document waste accurately and immediately.
• Teach patients with outpatient controlled substance prescriptions to: store medications securely (locked), never share with others, and dispose of unused medications at authorized collection sites or through National Take Back events.
• Report any observed signs of colleague drug diversion or SUD to the charge nurse and supervisor per facility policy; document observations objectively.
• Check current evidence-based drug references for boxed warning status before administering any unfamiliar medication.

Controlled Substance Waste — Never Dispose Alone

Waste of a controlled substance requires the co-signature of a second licensed staff member. Wasting alone and documenting it is irregular practice that will be flagged during inventory audits and may constitute grounds for a drug diversion investigation.

Clinical Judgment Application

Clinical Scenario

A nurse reviews the controlled substance count at shift start and finds that five morphine doses are documented as wasted over the previous 12-hour shift, all signed by the same two nurses. Patients who were assigned to one of those nurses during that shift have consistently reported severe, unrelieved pain.

• Recognize Cues: High opioid wastage documented over one shift; patients of one nurse reporting consistently unrelieved pain.
• Analyze Cues: The combination of excessive wastage and inadequate analgesia in assigned patients suggests opioid diversion — the nurse may be documenting waste while self-administering the medication.
• Prioritize Hypotheses: Drug diversion with patient harm is the highest-priority hypothesis.
• Generate Solutions: Report observations to charge nurse and nursing supervisor per facility policy; preserve records; avoid confronting the nurse directly.
• Take Action: Escalate to charge nurse immediately; document findings objectively; allow the formal investigation process to proceed.
• Evaluate Outcomes: Formal investigation is initiated; patients receive appropriate analgesia; affected nurse is referred to employee health and professional assistance program.

Related Concepts

• professional-standards-nursing-process — ANA Code of Ethics Provision 3 establishes the ethical obligation to report drug diversion.
• medication-administration-safety-measures — Controlled substance handling rules are part of the overall safe medication administration framework.
• opioids — Opioids are predominantly Schedule II controlled substances with the highest nursing vigilance requirements.

Self-Check

1. A patient is prescribed oxycodone 10 mg for pain, but the nurse only administers 5 mg. What must happen to the remaining 5 mg, and what documentation is required?
2. A provider calls the nurse with a verbal order for a Schedule II opioid. What is the nurse’s appropriate response?
3. A newly approved antibiotic is prescribed for a patient. Before administration, the nurse checks the drug reference and finds a boxed warning for tendon rupture. What action should the nurse take?
4. Name two behavioral and two drug-diversion-pattern signs that may indicate a colleague has substance use disorder. What is the nurse’s reporting obligation?
5. List the five DEA drug schedules and provide one clinical example drug for each schedule.